Download PDF
Semin Respir Crit Care Med 2022; 43(04): 559-569
DOI: 10.1055/s-0042-1748185
Review Article

Management of Malignant Pleural Effusion: Where Are We Now?

Julien Guinde
1   Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North University Hospital, Marseille, France
,
Hervé Dutau
1   Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North University Hospital, Marseille, France
,
Philippe Astoul
1   Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, North University Hospital, Marseille, France
2   Aix-Marseille University, Marseille, France
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Pleural malignancies are among the most common causes of pleural disease and form the basis of our daily pleural practice. There has been significant research and increase in both diagnostic and therapeutic management of malignant pleural diseases in the last decade. Good-quality data have led to a paradigm shift in the management options of pleural malignancies, and indwelling pleural catheter is now recommended and widely used as first-line intervention. Several trials compared different treatment modalities for pleural malignancies and continue to emphasize the need to reduce hospital length of stay and unnecessary pleural intervention, and the importance of patient choice in clinical decision making. This practical review aims to summarize the current knowledge for the management of pleural malignancies, and the understanding of the steps that we still have to climb to optimize management and reduce morbidity.

Keywords

pleural effusion - pleural malignancy - talc - indwelling pleural catheter - thoracoscopy


Publication History

Article published online:
25 May 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Boylan A, Broaddus V. Tumours of the pleura. Murray and Nadel's Textbook of Respiratory Medicine. 4th ed. Philadelphia, PA: Elsevier; 2019
    Google Scholar
  • 2 Thomas R, Francis R, Davies HE, Lee YCG. Interventional therapies for malignant pleural effusions: the present and the future. Respirology 2014; 19 (06) 809-822
    CrossrefPubMedGoogle Scholar
  • 3 Porcel JM, Esquerda A, Vives M, Bielsa S. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol 2014; 50 (05) 161-165
    CrossrefPubMedGoogle Scholar
  • 4 Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J 1997; 10 (08) 1907-1913
    CrossrefPubMedGoogle Scholar
  • 5 Porcel JM, Gasol A, Bielsa S, Civit C, Light RW, Salud A. Clinical features and survival of lung cancer patients with pleural effusions. Respirology 2015; 20 (04) 654-659
    CrossrefPubMedGoogle Scholar
  • 6 Clive AO, Kahan BC, Hooper CE. et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax 2014; 69 (12) 1098-1104
    CrossrefPubMedGoogle Scholar
  • 7 Psallidas I, Kanellakis NI, Gerry S. et al. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis. Lancet Oncol 2018; 19 (07) 930-939
    CrossrefPubMedGoogle Scholar
  • 8 Fortin M, Taghizadeh N, Tremblay A. Procedures performed during hospitalizations for malignant pleural effusions: data from the 2012 National Inpatient Sample. Respiration 2018; 95 (04) 228-234
    CrossrefPubMedGoogle Scholar
  • 9 Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev 2020; 4: CD010529
    PubMedGoogle Scholar
  • 10 Heffner JE, Klein JS. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 2008; 83 (02) 235-250
    CrossrefPubMedGoogle Scholar
  • 11 Corcoran JP, Tazi-Mezalek R, Maldonado F. et al. State of the art thoracic ultrasound: intervention and therapeutics. Thorax 2017; 72 (09) 840-849
    PubMedGoogle Scholar
  • 12 Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 2009; 64 (02) 139-143
    CrossrefPubMedGoogle Scholar
  • 13 Porcel JM, Light RW. Pleural effusions. Dis Mon 2013; 59 (02) 29-57
    CrossrefPubMedGoogle Scholar
  • 14 Gordon CE, Feller-Kopman D, Balk EM, Smetana GW. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med 2010; 170 (04) 332-339
    CrossrefPubMedGoogle Scholar
  • 15 Mercaldi CJ, Lanes SF. Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis. Chest 2013; 143 (02) 532-538
    CrossrefPubMedGoogle Scholar
  • 16 Jiang B, Li X-L, Yin Y. et al. Ultrasound elastography: a novel tool for the differential diagnosis of pleural effusion. Eur Respir J 2019; 54 (02) 1802018
    CrossrefPubMedGoogle Scholar
  • 17 Dresler CM, Olak J, Herndon II JE. et al; Cooperative Groups Cancer and Leukemia Group B, Eastern Cooperative Oncology Group, North Central Cooperative Oncology Group, Radiation Therapy Oncology Group. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005; 127 (03) 909-915
    CrossrefPubMedGoogle Scholar
  • 18 Feller-Kopman DJ, Reddy CB, DeCamp MM. et al. Management of malignant pleural effusions. an official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med 2018; 198 (07) 839-849
    CrossrefPubMedGoogle Scholar
  • 19 Martin GA, Kidd AC, Tsim S. et al. Inter-observer variation in image interpretation and the prognostic importance of non-expansile lung in malignant pleural effusion. Respirology 2019; DOI: 10.1111/resp.13681.
    CrossrefPubMedGoogle Scholar
  • 20 Salamonsen MR, Lo AKC, Ng ACT, Bashirzadeh F, Wang WYS, Fielding DIK. Novel use of pleural ultrasound can identify malignant entrapped lung prior to effusion drainage. Chest 2014; 146 (05) 1286-1293
    CrossrefPubMedGoogle Scholar
  • 21 Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990; 154 (03) 487-492
    CrossrefPubMedGoogle Scholar
  • 22 Porcel JM, Pardina M, Bielsa S, González A, Light RW. Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions. Chest 2015; 147 (02) 513-519
    CrossrefPubMedGoogle Scholar
  • 23 Porcel JM, Hernández P, Martínez-Alonso M, Bielsa S, Salud A. Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis. Chest 2015; 147 (02) 502-512
    CrossrefPubMedGoogle Scholar
  • 24 Vandemoortele T, Laroumagne S, Roca E. et al. Positive FDG-PET/CT of the pleura twenty years after talc pleurodesis: three cases of benign talcoma. Respiration 2014; 87 (03) 243-248
    CrossrefPubMedGoogle Scholar
  • 25 Davies HE, Davies RJO, Davies CWH. BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl. 02) ii41-ii53
    PubMedGoogle Scholar
  • 26 Swiderek J, Morcos S, Donthireddy V. et al. Prospective study to determine the volume of pleural fluid required to diagnose malignancy. Chest 2010; 137 (01) 68-73
    CrossrefPubMedGoogle Scholar
  • 27 Abouzgheib W, Bartter T, Dagher H, Pratter M, Klump W. A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion. Chest 2009; 135 (04) 999-1001
    CrossrefPubMedGoogle Scholar
  • 28 Arnold DT, De Fonseka D, Perry S. et al. Investigating unilateral pleural effusions: the role of cytology. Eur Respir J 2018; 52 (05) 1801254
    CrossrefPubMedGoogle Scholar
  • 29 Pinelli V, Laroumagne S, Sakr L, Marchetti GP, Tassi GF, Astoul P. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma. J Thorac Oncol 2012; 7 (03) 595-598
    CrossrefPubMedGoogle Scholar
  • 30 Froudarakis ME, Plojoux J, Kaspi E. et al. Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions. Clin Respir J 2017; DOI: 10.1111/crj.12619.
    CrossrefPubMedGoogle Scholar
  • 31 Barlesi F, Mazieres J, Merlio J-P. et al; Biomarkers France Contributors. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet 2016; 387 (10026): 1415-1426
    CrossrefPubMedGoogle Scholar
  • 32 Carter J, Miller JA, Feller-Kopman D, Ettinger D, Sidransky D, Maleki Z. Molecular profiling of malignant pleural effusion in metastatic non-small-cell lung carcinoma. The effect of preanalytical factors. Ann Am Thorac Soc 2017; 14 (07) 1169-1176
    PubMedGoogle Scholar
  • 33 DeMaio A, Clarke JM, Dash R. et al. Yield of malignant pleural effusion for detection of oncogenic driver mutations in lung adenocarcinoma. J Bronchology Interv Pulmonol 2019; 26 (02) 96-101
    CrossrefPubMedGoogle Scholar
  • 34 Liu N, Sun R-Z, Du J. et al. Comparison of epidermal growth factor receptor gene mutations identified using pleural effusion and primary tumor tissue samples in non-small cell lung cancer. Appl Immunohistochem Mol Morphol 2018; 26 (04) e44-e51
    CrossrefPubMedGoogle Scholar
  • 35 Yang J, Lee O-J, Son S-M. et al. EGFR mutation status in lung adenocarcinoma-associated malignant pleural effusion and efficacy of EGFR tyrosine kinase inhibitors. Cancer Res Treat 2018; 50 (03) 908-916
    CrossrefPubMedGoogle Scholar
  • 36 Carbone DP, Reck M, Paz-Ares L. et al; CheckMate 026 Investigators. First-line nivolumab in stage IV or recurrent non-small-cell lung cancer. N Engl J Med 2017; 376 (25) 2415-2426
    CrossrefPubMedGoogle Scholar
  • 37 Reck M, Rodríguez-Abreu D, Robinson AG. et al; KEYNOTE-024 Investigators. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 2016; 375 (19) 1823-1833
    CrossrefPubMedGoogle Scholar
  • 38 Mok TSK, Wu Y-L, Kudaba I. et al; KEYNOTE-042 Investigators. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. Lancet 2019; 393 (10183): 1819-1830
    CrossrefPubMedGoogle Scholar
  • 39 Grosu HB, Arriola A, Stewart J. et al. PD-L1 detection in histology specimens and matched pleural fluid cell blocks of patients with NSCLC. Respirology 2019; 24 (12) 1198-1203
    CrossrefPubMedGoogle Scholar
  • 40 PD-L1 expression in pleural effusions of pulmonary adenocarcinoma and survival prediction: a controlled study by pleural biopsy | Scientific Reports [Internet]. [cited 2019 Dec 11]. Accessed February 28, 2022 at: https://www.nature.com/articles/s41598-018-29156-5
    PubMedGoogle Scholar
  • 41 Heymann JJ, Bulman WA, Swinarski D. et al. PD-L1 expression in non-small cell lung carcinoma: comparison among cytology, small biopsy, and surgical resection specimens. Cancer Cytopathol 2017; 125 (12) 896-907
    CrossrefPubMedGoogle Scholar
  • 42 Gandhi L, Rodríguez-Abreu D, Gadgeel S. et al; KEYNOTE-189 Investigators. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 2018; 378 (22) 2078-2092
    CrossrefPubMedGoogle Scholar
  • 43 Lentz RJ, Shojaee S, Grosu HB. et al. The impact of gravity vs suction-driven therapeutic thoracentesis on pressure-related complications: the GRAVITAS Multicenter Randomized Controlled Trial. Chest 2019; DOI: 10.1016/j.chest.2019.10.025.
    CrossrefPubMedGoogle Scholar
  • 44 Psallidas I, Yousuf A, Talwar A. et al. Assessment of patient-reported outcome measures in pleural interventions. BMJ Open Respir Res 2017; 4 (01) e000171
    CrossrefPubMedGoogle Scholar
  • 45 Thomas R, Jenkins S, Eastwood PR, Lee YCG, Singh B. Physiology of breathlessness associated with pleural effusions. Curr Opin Pulm Med 2015; 21 (04) 338-345
    CrossrefPubMedGoogle Scholar
  • 46 Lentz RJ, Lerner AD, Pannu JK. et al. Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial. Lancet Respir Med 2019; 7 (05) 447-455
    CrossrefPubMedGoogle Scholar
  • 47 Martin GA, Tsim S, Kidd AC. et al. Pre-EDIT: a randomized feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis in malignant pleural effusion. Chest 2019; 156 (06) 1204-1213
    CrossrefPubMedGoogle Scholar
  • 48 Martin GA, Tsim S, Kidd AC. et al. Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion. BMJ Open Respir Res 2018; 5 (01) e000293
    PubMedGoogle Scholar
  • 49 Bibby AC, Dorn P, Psallidas I. et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur Respir J 2018; 52 (01) 1800349
    CrossrefPubMedGoogle Scholar
  • 50 Rahman NM, Gleeson FV. Image-guided pleural biopsy. Curr Opin Pulm Med 2008; 14 (04) 331-336
    CrossrefPubMedGoogle Scholar
  • 51 Maskell NA, Gleeson FV, Davies RJO. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003; 361 (9366): 1326-1330
    CrossrefPubMedGoogle Scholar
  • 52 de Fonseka D, Underwood W, Stadon L. et al. Randomised controlled trial to compare the diagnostic yield of positron emission tomography CT (PET-CT) TARGETed pleural biopsy versus CT-guided pleural biopsy in suspected pleural malignancy (TARGET trial). BMJ Open Respir Res 2018; 5 (01) e000270
    CrossrefPubMedGoogle Scholar
  • 53 Diacon AH, Schuurmans MM, Theron J, Schubert PT, Wright CA, Bolliger CT. Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists. Respiration 2004; 71 (05) 519-522
    CrossrefPubMedGoogle Scholar
  • 54 Chang DB, Yang PC, Luh KT, Kuo SH, Yu CJ. Ultrasound-guided pleural biopsy with Tru-Cut needle. Chest 1991; 100 (05) 1328-1333
    CrossrefPubMedGoogle Scholar
  • 55 Harris RJ, Kavuru MS, Rice TW, Kirby TJ. The diagnostic and therapeutic utility of thoracoscopy: a review. Chest 1995; 108 (03) 828-841
    CrossrefPubMedGoogle Scholar
  • 56 Rahman NM, Ali NJ, Brown G. et al; British Thoracic Society Pleural Disease Guideline Group. Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl. 02) ii54-ii60
    PubMedGoogle Scholar
  • 57 Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med 1991; 114 (04) 271-276
    CrossrefPubMedGoogle Scholar
  • 58 Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 1993; 72 (02) 389-393
    CrossrefPubMedGoogle Scholar
  • 59 Froudarakis ME, Anevlavis S, Marquette C-H, Astoul P. Medical thoracoscopy implementation after a European Respiratory Society Course Held from 2003 to 2016: a survey. Respiration 2021; 100 (06) 523-529
    CrossrefPubMedGoogle Scholar
  • 60 Bendixen M, Jørgensen OD, Kronborg C, Andersen C, Licht PB. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial. Lancet Oncol 2016; 17 (06) 836-844
    Google Scholar
  • 61 Corcoran JP, Psallidas I, Hallifax RJ, Talwar A, Sykes A, Rahman NM. Ultrasound-guided pneumothorax induction prior to local anaesthetic thoracoscopy. Thorax 2015; 70 (09) 906-908
    CrossrefPubMedGoogle Scholar
  • 62 Bedawi EO, Talwar A, Hassan M. et al. Intercostal vessel screening prior to pleural interventions by the respiratory physician: a prospective study of real world practice. Eur Respir J 2020; 55 (04) 1902245
    CrossrefPubMedGoogle Scholar
  • 63 Thiam K, Guinde J, Laroumagne S. et al. Lateral decubitus chest radiography or chest ultrasound to predict pleural adhesions before medical thoracoscopy: a prospective study. J Thorac Dis 2019; 11 (10) 4292-4297
    CrossrefPubMedGoogle Scholar
  • 64 Dhooria S, Singh N, Aggarwal AN, Gupta D, Agarwal R. A randomized trial comparing the diagnostic yield of rigid and semirigid thoracoscopy in undiagnosed pleural effusions. Respir Care 2014; 59 (05) 756-764
    CrossrefPubMedGoogle Scholar
  • 65 Thomas R, Karunarathne S, Jennings B. et al. Pleuroscopic cryoprobe biopsies of the pleura: a feasibility and safety study. Respirology 2015; 20 (02) 327-332
    CrossrefPubMedGoogle Scholar
  • 66 Quek JC, Tan QL, Allen JC, Anantham D. Malignant pleural effusion survival prognostication in an Asian population. Respirology 2020; 25 (12) 1283-1291
    CrossrefPubMedGoogle Scholar
  • 67 Abisheganaden J, Verma A, Dagaonkar RS, Light RW. An observational study evaluating the performance of LENT score in the selected population of malignant pleural effusion from lung adenocarcinoma in Singapore. Respiration 2018; 96 (04) 308-313
    CrossrefPubMedGoogle Scholar
  • 68 Chollet B, Guinde J, Laroumagne S, Dutau H, Astoul P. Does the LENT score risk-stratify patients with malignant pleural mesothelioma? An observational study. Thorac Cancer 2021; 12 (11) 1752-1756
    CrossrefPubMedGoogle Scholar
  • 69 Brims FJH, Meniawy TM, Duffus I. et al. A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis. J Thorac Oncol 2016; 11 (04) 573-582
    CrossrefPubMedGoogle Scholar
  • 70 Rodriguez-Panadero F, Montes-Worboys A. Mechanisms of pleurodesis. Respiration 2012; 83 (02) 91-98
    CrossrefPubMedGoogle Scholar
  • 71 Clive AO, Jones HE, Bhatnagar R, Preston NJ, Maskell N. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev 2016; (05) CD010529
    PubMedGoogle Scholar
  • 72 Rahman NM, Pepperell J, Rehal S. et al. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: the TIME1 Randomized Clinical Trial. JAMA 2015; 314 (24) 2641-2653
    CrossrefPubMedGoogle Scholar
  • 73 Janssen JP, Collier G, Astoul P. et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007; 369 (9572): 1535-1539
    CrossrefPubMedGoogle Scholar
  • 74 Bhatnagar R, Piotrowska HEG, Laskawiec-Szkonter M. et al. Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial. JAMA 2020; 323 (01) 60-69
    CrossrefPubMedGoogle Scholar
  • 75 Fysh ETH, Tremblay A, Feller-Kopman D. et al. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest 2013; 144 (05) 1597-1602
    CrossrefPubMedGoogle Scholar
  • 76 Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006; 129 (02) 362-368
    CrossrefPubMedGoogle Scholar
  • 77 Putnam Jr JB, Light RW, Rodriguez RM. et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999; 86 (10) 1992-1999
    CrossrefPubMedGoogle Scholar
  • 78 Thomas R, Fysh ETH, Smith NA. et al. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE Randomized Clinical Trial. JAMA 2017; 318 (19) 1903-1912
    CrossrefPubMedGoogle Scholar
  • 79 Warren WH, Kim AW, Liptay MJ. Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg 2008; 33 (01) 89-94
    CrossrefPubMedGoogle Scholar
  • 80 Fitzgerald DB, Muruganandan S, Tsim S. et al. Intrapleural fibrinolytics and deoxyribonuclease for treatment of indwelling pleural catheter-related pleural infection: a multi-center observational study. Respiration 2021; 100 (05) 452-460
    CrossrefPubMedGoogle Scholar
  • 81 Van Meter MEM, McKee KY, Kohlwes RJ. Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med 2011; 26 (01) 70-76
    CrossrefPubMedGoogle Scholar
  • 82 Wahidi MM, Reddy C, Yarmus L. et al. Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. the ASAP trial. Am J Respir Crit Care Med 2017; 195 (08) 1050-1057
    CrossrefPubMedGoogle Scholar
  • 83 Muruganandan S, Azzopardi M, Fitzgerald DB. et al. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial. Lancet Respir Med 2018; 6 (09) 671-680
    CrossrefPubMedGoogle Scholar
  • 84 Davies HE, Mishra EK, Kahan BC. et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA 2012; 307 (22) 2383-2389
    CrossrefPubMedGoogle Scholar
  • 85 Olfert JAP, Penz ED, Manns BJ. et al. Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion. Respirology 2017; 22 (04) 764-770
    CrossrefPubMedGoogle Scholar
  • 86 Reddy C, Ernst A, Lamb C, Feller-Kopman D. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest 2011; 139 (06) 1419-1423
    CrossrefPubMedGoogle Scholar
  • 87 Boujaoude Z, Bartter T, Abboud M, Pratter M, Abouzgheib W. Pleuroscopic pleurodesis combined with tunneled pleural catheter for management of malignant pleural effusion: a prospective observational study. J Bronchology Interv Pulmonol 2015; 22 (03) 237-243
    CrossrefPubMedGoogle Scholar
  • 88 Bhatnagar R, Keenan EK, Morley AJ. et al. Outpatient talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med 2018; 378 (14) 1313-1322
    CrossrefPubMedGoogle Scholar
  • 89 Ahmed L, Ip H, Rao D, Patel N, Noorzad F. Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway. Chest 2014; 146 (06) e190-e194
    CrossrefPubMedGoogle Scholar
  • 90 Tremblay A, Kearney CT, Hanks C. et al. Local and systemic effects of a silver nitrate coated indwelling pleural catheter in an animal model of pleurodesis. Exp Lung Res 2017; 43 (9-10): 388-394
    CrossrefPubMedGoogle Scholar
  • 91 Bhatnagar R, Zahan-Evans N, Kearney C. et al. A novel drug-eluting indwelling pleural catheter for the management of malignant effusions. Am J Respir Crit Care Med 2018; 197 (01) 136-138
    CrossrefPubMedGoogle Scholar